Abstract
PurposeDabigatran is a direct thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Real-world data about patient preference, satisfaction and convenience in patients in Asia are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have